United States Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
September 17, 2014
122 Pages - SKU: BMI5329158
Countries covered: United States

United States Pharmaceuticals and Healthcare Report Q4 2014

BMI View: The US pharmaceutical market presents strong commercial opportunities across the industry.Total US pharmaceutical sales reached USD347.2bn in 2013 - more than three times the size of its nearestrival Japan. The US boasts the largest individual markets across the three core sub-sectors: patented, genericand over-the-counter medicines. State-level pharmaceutical markets in the country are larger than manycountry-level pharmaceutical markets.

Headline Expenditure Projections

Pharmaceuticals: USD347.2bn in 2013 to USD352.8bn in 2014; 1.6% growth in local currency terms.Forecast unchanged from Q314.

Healthcare: USD2,918bn in 2013 to USD3,112bn in 2014; +6.7% growth in local currency terms.Forecast unchanged from Q314.



More Manufacturing, Packaging & Detailing reports by Business Monitor International

Venezuela Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q4 2014BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports frompolitical allies and the potential expansion of free medicine ...
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescriptionnumbers, does not come ...
Switzerland Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q4 2014BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The proportion of ...
Qatar Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Qatar Pharmaceuticals and Healthcare Report Q4 2014BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental topharmaceutical ...
See all reports like this >>

More United States Manufacturing, Packaging & Detailing reports

Biological Product (except Diagnostic) Manufacturing Industry in the U.S. and its International Trade [2014 Q4 Edition] by Supplier Relations US, LLC
Biological Product (except Diagnostic) Manufacturing Industry in the U.S. and its International Trade [2014 Q4 Edition]The Biological Product (except Diagnostic) Manufacturing Industry report contains the ...
Pharmaceutical Preparation Manufacturing Industry in the U.S. and its International Trade [2014 Q4 Edition] by Supplier Relations US, LLC
Pharmaceutical Preparation Manufacturing Industry in the U.S. and its International Trade [2014 Q4 Edition]The Pharmaceutical Preparation Manufacturing Industry report contains the most recent data and ...
Medicinal and Botanical Manufacturing Industry in the U.S. and its International Trade [2014 Q4 Edition] by Supplier Relations US, LLC
Medicinal and Botanical Manufacturing Industry in the U.S. and its International Trade [2014 Q4 Edition]The Medicinal and Botanical Manufacturing Industry report contains the most recent ...
Pharmaceutical Manufacturing by First Research, Inc.
Pharmaceutical ManufacturingBrief Excerpt from Industry Overview Chapter:Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!